Woman’s sterilisation fight: serious questions over procedure access rights

• A psychologist successfully appealed an NHS refusal for sterilisation through the health ombudsman.
• Debates persist regarding bodily autonomy and alleged medical misogyny in female sterilisation access.
• Some experts suggest reversible contraception as a safer alternative to permanent female procedures.

Leah Spasova, a psychologist, successfully contested an NHS decision that denied her sterilisation. After taking the matter to the health ombudsman, she won her challenge. This case has sparked a broader debate regarding the accessibility of the procedure for women.

Statistical data shows female sterilisations fell by 22% over ten years, with 10,793 performed in 2024-25. In contrast, vasectomies rose by 16% annually, reaching 26,385. Critics argue these figures highlight inequality and a lack of trust in women’s choices.

Charlotte Glynn from the British Pregnancy Advisory Service suggests that women face medical misogyny when seeking these operations. She notes that some are deemed too young, regardless of their children. This often results in a postcode lottery for essential care.

Glynn argues that informed women should have their decisions respected despite surgical risks. She points out that unintended pregnancies carry significant costs. Furthermore, many women cannot tolerate the side-effects associated with contraceptive patches or pills.

Conversely, Professor Anna Glasier suggests that access is equitable. She notes that men also face long waiting lists for vasectomies. She emphasizes that the irreversible nature of the surgery is a concern for both genders.

Glasier advocates for long-acting reversible contraception, which lasts between 8 and 12 years. She notes that regret rates can reach 20%, particularly in younger patients. This makes reversible options a sensible alternative to permanent surgery.